CervoMed (CRVO) said Thursday it has struck a deal to sell 2.5 million shares at $4.00 per share in a registered direct offering, with H.C. Wainwright as the placement agent.
The clinical-stage biotechnology company said it plans to use the net proceeds for working capital and general corporate purposes. It expects to close the deal June 22.
Price: $5.43, Change: $+1.62, Percent Change: +42.52%